Presentation EuroPCR 2013 Repositionable Percutaneous Replacement of a Stenotic Aortic Valve through Implantation of the Lotus Valve System Presenter: 203171|Ian Meredith May 31, 2013
Presentation EuroPCR 2013 First Report of One-Year Outcomes of the REPRISE I Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System Presenter: 203171|Ian Meredith May 31, 2013
Presentation EuroPCR 2013 Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent Presenter: 203171|Ian Meredith May 31, 2013
Presentation EuroPCR 2013 Clinical evidence in catheter-based renal sympathetic denervation - building the data Presenter: 161082|Joachim Schofer May 31, 2013
Presentation Vascular and Upper Gastrointestinal Effects of Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Presenter: CNT Collaboration May 31, 2013
Presentation Aortic Stenosis in the Elderly: Disease Prevalence and Number of Candidates for TAVR Presenter: 201433|Ruben L. J. Osnabrugge May 30, 2013
Presentation Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After TAVI Presenter: O. Husser May 29, 2013
Presentation The Impact of Integration of a Multidetector CT Annulus Area Sizing Algorithm on TAVR Outcomes Presenter: R. K. Binder May 28, 2013
Presentation Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy Presenter: M. Urena May 28, 2013